245
Participants
Start Date
February 7, 2022
Primary Completion Date
August 31, 2023
Study Completion Date
August 31, 2023
Clinical assessment
All participants will be invited to attend their local research facility to undergo a physical and questionnaire assessment as well as an MRI. Assessments include: Expanded Disability Status Scale, 9-Hole Peg Test, MRI scan, Patient Reported Outcome Measures (MSIS-29, neuroQOL and PROMIS), Brief International Cognitive Assessment for MS)
Clinical Research Facility, Glasgow
Collaborators (1)
Biogen
INDUSTRY
NHS Greater Glasgow and Clyde
OTHER